Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease

NCT02921620 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Protocol not feasible

Conditions

Fabry Disease

Interventions

BIOLOGICAL: PRX-102
OTHER: Placebo

Sponsor

Protalix